{
    "eid": "2-s2.0-85131457445",
    "title": "Survival outcomes with warfarin compared with direct oral anticoagulants in cancer-associated venous thromboembolism in the United States: A population-based cohort study",
    "cover-date": "2022-05-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Adeel M. Khan",
        "Thita Chiasakul",
        "Robert Redd",
        "Rushad Patell",
        "Ellen P. McCarthy",
        "Donna Neuberg",
        "Jeffrey I. Zwicker"
    ],
    "citedby-count": 0,
    "ref-count": 40,
    "ref-list": [
        "Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy",
        "Epidemiology of venous thromboembolism",
        "Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer",
        "Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism",
        "Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)",
        "Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial",
        "Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer",
        "Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer",
        "Overall survival with warfarin vs. low-molecular-weight heparin in cancer-associated thrombosis",
        "Anticoagulants and cancer mortality in the Finnish randomized study of screening for prostate cancer",
        "Association of Warfarin Use With Lower Overall Cancer Incidence Among Patients Older Than 50 Years",
        "Procoagulant activity of the MC28 fibrosarcoma cell line in vitro and in vivo",
        "Warfarin inhibition of metastasis: The role of anticoagulation",
        "A study of the mechanism by which anticoagulation with warfarin inhibits blood-borne metastases",
        "Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1\u2013Dependent Immune Evasion",
        "Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation",
        "Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis",
        "Thrombin Drives Tumorigenesis in Colitis-Associated Colon Cancer",
        "Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis",
        "Updated Overview of the SEER-Medicare Data: Enhanced Content and Applications",
        "Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States",
        "Identifying Increased Risk of Readmission and In-hospital Mortality Using Hospital Administrative Data: The AHRQ Elixhauser Comorbidity Index",
        "Comparison of different comorbidity measures for use with administrative data in predicting short- and long-term mortality",
        "Comparing Charlson and Elixhauser comorbidity indices with different weightings to predict in-hospital mortality: an analysis of national inpatient data",
        "Oral rivaroxaban for symptomatic venous thromboembolism",
        "Oral rivaroxaban for the treatment of symptomatic pulmonary embolism",
        "Direct Oral Anticoagulants in Cancer Patients. Time for a Change in Paradigm",
        "Anticoagulants and Breast Cancer Survival: A Nationwide Cohort Study",
        "Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer",
        "Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial",
        "Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF\u2014TIMI 48 Trial",
        "Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study",
        "The effect of Warfarin and factor VII on tissue procoagulant activity and pulmonary seeding",
        "Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis",
        "Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75",
        "Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study",
        "Incidence of Cancer after Prophylaxis with Warfarin against Recurrent Venous Thromboembolism"
    ],
    "affiliation": [
        {
            "affiliation-city": "Boston",
            "@id": "60002746",
            "affilname": "Harvard Medical School",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002746",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60014334",
            "affilname": "Dana-Farber Cancer Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014334",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "National Heart, Lung, and Blood Institute CLOT Consortium"
    ]
}